StreetAlpha.app
Home › Stocks › SOPH

SOPHiA GENETICS SA (SOPH)

Healthcare
$6.23
▼ −6.74%
LAST CLOSE · NOV 20

SOPHiA GENETICS sells a cloud based software platform that analyzes medical data for hospitals, labs and drug companies. It last closed at $6.23 on Nov 20, down 6.74% on the day. Over the last 12 months SOPH insiders bought $377K of stock on the open market and sold $5.4M, according to SEC Form 4 filings.

AI Auto Pilots
Is SOPH in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold SOPH.

Key Stats

Last 12 months
Results
Revenue
$77.3M
+18.6% vs a year ago
Net income
−$79.0M
−102.2% margin
Free cash flow
−$36.5M
−47.2% margin
Gross margin
67.4%
$52.1M gross profit
Balance sheet
Cash & equivalents
$70.3M
At Dec 31
Shareholder equity
$47.1M
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $40.5M$40.5MFY2021FY2022: $47.6M$47.6MFY2022FY2023: $62.4M$62.4MFY2023FY2024: $65.2M$65.2MFY2024FY2025: $77.3M$77.3MFY2025

From SOPH's SEC filings, latest 20-F for the period ending Dec 31, 2025 (filed Mar 3). Last 12 months adds up the four latest quarters. Per share figures are left out because the US listing can represent a different number of shares.

Next report
—
No date on file yet
Reported EPS
—
Quarter ended Jun 2025
Year ago EPS
—
Same quarter last year
Revenue
$18.3M
+15.9% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Not enough quarters on file yet.
Revenue by quarter
Jun 2022: $11.7MJun '22Jun 2023: $15.1MJun '23Jun 2024: $15.8MJun '24Jun 2025: $18.3MJun '25Latest $18.3M
StreetAlpha's call on SOPHStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on SOPH
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on SOPH

Technical Analysis

SOPH · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 18% below its 20 day and 21% below its 50 day average. It is 2% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 37), near oversold. The nearest support is the 200 day average at $6.10, and the nearest resistance the swing high (Jun 30) at $6.30.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 9.6%/day
Key levels
$8.9852 week high+44.1%
$7.5650 day average+21.3%
$7.3720 day average+18.3%
$7.27100 day average+16.7%
$6.69Pivot R1+7.4%
$6.42Pivot+3.0%
$6.30Swing high (Jun 30)+1.1%
$6.23Last close
$6.10200 day average−2.1%
$5.97Pivot S1−4.2%
$5.92Swing low (Nov 3)−5.0%
$3.8352 week low−38.5%
Indicators
RSI (14)37.26Weak, oversold below 30Neutral
MACD-0.13Below its signal lineBearish
Stochastic36.4Middle of its rangeNeutral
ADX (14)14.7No clear trend
Williams %R-87.1Oversold below −80, overbought above −20Oversold
CCI (20)-170.8Oversold below −100, overbought above 100Oversold
Rate of change−12.8%Change over 10 sessionsBearish
ATR (14)$0.60Typical daily range, 9.6% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for SOPH

What happened before

See how SOPH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow SOPH usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How SOPH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2021.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for SOPHHow many large options trades hit SOPH, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

SOPH Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲57 buying vs 36 selling
  • ▲Held by funds +6.0 pts
  • ▲Funds holding +20
  • ▲Superinvestors: 4 added, 0 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding9373+27.4%
In funds' top 10110.0%
Held by funds59.9%53.8%+6.0 pts
New / increased31 / 2628 / 16+29.5%
Reduced / sold out25 / 1115 / 4+89.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See SOPH institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

SOPH Insider Trading

All filings →
Insider trading · 12 months
Insiders are net sellers
Bought$377K3 buys · 2 insiders
Sold$5.4M116 sales · 10 insiders
99% of the selling was under pre-arranged trading plans.
Cluster buy: 2 insiders bought $278K between Nov 6 and Nov 6.
2026-03 sold $42K2026-04 sold $926K2026-05 sold $179K2026-06 bought $99K2026-06 sold $966K2026-07 sold $811K2026-08 sold $1.2M2026-09 sold $244K2026-10 sold $796K2026-11 bought $278K2026-11 sold $205KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Well Daan VanChief Legal OfficerSale plan1,224$7.73$9K
Nov 13Zhenyu XuChief Scientific OfficerSale plan4,000$7.96$32K
Nov 12Philippe MenuChief Medical OfficerSale plan5,000$7.68$38K
Nov 10Jurgi CamblongExecutive ChairmanSale plan8,500$7.76$66K
Nov 10Kathy L HibbsDirectorSale plan6,250$7.76$48K
Nov 9Well Daan VanChief Legal OfficerSale plan1,411$7.44$10K
Every insider buy and sale for SOPH over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See SOPH insider trades →

From SEC Form 4 filings by SOPH's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether SOPH is in one of them and how their past SOPH trades turned out.

SOPH in the AI portfolios
Loading…

SOPH News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered SOPH in an article yet. Here's the latest on the wider market.

SOPH in the news

About SOPHiA GENETICS SA

SOPHiA GENETICS is a software company based in Rolle, Switzerland. Its cloud based platform, SOPHiA DDM, standardizes and analyzes health data such as genomic, radiomic and clinical information, so institutions can share insights without moving their samples or data. The company sells mainly to hospitals, clinical and research laboratories, and biopharmaceutical companies.

Headquarters
Rolle, Switzerland